TrianglePUBLICATIONS · 33504555
Long-Term Follow-up of a Phase III Study of ch14.18 (Dinutuximab) + Cytokine Immunotherapy in Children with High-Risk Neuroblastoma: COG Study ANBL0032.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Clin Cancer Res
- Publication date
- 2021 Apr 15
- First author
- Yu AL
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Yu AL
- type
- Author
- name
- Gilman AL
- type
- Author
- name
- Ozkaynak MF
- type
- Author
- name
- Naranjo A
- type
- Author
- name
- Diccianni MB
- type
- Author
- name
- Gan J
- type
- Author
- name
- Hank JA
- type
- Author
- name
- Batova A
- type
- Author
- name
- London WB
- type
- Author
- name
- Tenney SC
- type
- Author
- name
- Smith M
- type
- Author
- name
- Shulkin BL
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Yu AL
- type
- Author
- name
- Gilman AL
- type
- Author
- name
- Ozkaynak MF
- type
- Author
- name
- Naranjo A
- type
- Author
- name
- Diccianni MB
- type
- Author
- name
- Gan J
- type
- Author
- name
- Hank JA
- type
- Author
- name
- Batova A
- type
- Author
- name
- London WB
- type
- Author
- name
- Tenney SC
- type
- Author
- name
- Smith M
- type
- Author
- name
- Shulkin BL
- type
- Author
- bibliography ids
- nci-bib-bdad709b4b84c42942726307
- book metadata
- content sha256
- 404d3206b944e41439dfc164ef1adad07f48d879aa3e789e7261496608bae2d2
- document type
- citation
- dois
- 10.1158/1078-0432.CCR-20-3909
- electronic publication date
- display
- 2021 Jan 27
- precision
- day
- year
- 2021
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:33504555
- immutable id
- pubmed:33504555@404d3206b944e41439dfc164ef1adad07f48d879aa3e789e7261496608bae2d2
- journal
- abbreviation
- Clin Cancer Res
- issn electronic
- 1557-3265
- issn print
- 1078-0432
- issue
- 8
- name
- Clinical cancer research : an official journal of the American Association for Cancer Research
- nlm unique id
- 9502500
- pages
- 2179-2189
- volume
- 27
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 33504555
- provenance
- batch id
- 79f1021053e858d13ff3
- provider
- NCBI PubMed ESummary
- record sha256
- c11ff724e3d396a3e9ee5480cf6139103d67d52ca543ca187793c7284580b155
- response sha256
- 671d3d2962f73c698a1cb338d73222e2cc6cfdf61569f91b42612d5b59822e05
- retrieved at
- 2026-09-09T23:47:59.098265+00:00
- publication date
- display
- 2021 Apr 15
- precision
- day
- year
- 2021
- publication types
- Clinical Trial, Phase III
- Journal Article
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Long-Term Follow-up of a Phase III Study of ch14.18 (Dinutuximab) + Cytokine Immunotherapy in Children with High-Risk Neuroblastoma: COG Study ANBL0032.
Preserved source evidence · Not medical advice